Gelonghui, January 5 | Huaren Pharmaceutical (300110.SZ) said on the investor interactive platform that the company is mainly engaged in R&D, production and sales of peritoneal dialysis solutions, respiratory medicine, large infusions (including non-PVC soft bags, plastic bottles, large glass bottles), drugs used in the field of refining and raw materials, supporting pharmaceutical packaging materials, and medical devices. The company currently has no products or orders related to COVID-19 testing.
华仁药业(300110.SZ)：公司目前无新冠检测相关产品及订单
Huaren Pharmaceutical (300110.SZ): The company currently has no products or orders related to COVID-19 testing
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.